SAS-B approvals slow in August but pastille scripts continue to rise by Steve Jones September 3, 2025February 21, 2026 Pastilles are edging closer to becoming the second most prescribed dosage form through the Special Access […]
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
SAS-B deep dive: approvals up 27% as flower officially overtakes oil by Adam Sheldon July 3, 2025July 3, 2025
May SAS-B approvals slip from April record but still close to 20,000 by Steve Jones June 3, 2025June 3, 2025
SAS-B approvals hit all-time high in April as Tasmania spikes again by Steve Jones May 2, 2025May 2, 2025
SAS-B approvals hit second highest on record as Tassie shows surprise growth by Steve Jones April 2, 2025April 2, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
Growth of pastilles accelerates as SAS approvals get off to strong start in 2025 by Steve Jones February 17, 2025February 17, 2025
SAS-B deep dive: approvals soar in ’24 with category five medicine leading the charge by Steve Jones January 22, 2025January 22, 2025
TGA ‘exploring’ patient safety but stresses importance of ‘timely access’ to medicinal cannabis by Steve Jones January 14, 2025January 14, 2025
